<DOC>
	<DOCNO>NCT01267526</DOCNO>
	<brief_summary>This Canadian , Multicentre , Observational Registry study Adherence Long Term Outcomes Therapy paediatric subject use Easypod™ electromechanical device growth hormone treatment hospital ass level adherence subject receive SAIZEN® via Easypod™ .</brief_summary>
	<brief_title>A Canadian , Multi-centre , Observational Registry Study Adherence Long Term Outcomes Therapy Pediatric Subjects Using SAIZEN® Via Easypod™ Auto-injector Growth Hormone Treatment</brief_title>
	<detailed_description>Subjects enrol multicenter , longitudinal observational registry . Parents/subjects provide Informed Consent/assent upload data populationbased analysis optionally adhere patient adherence support program design improve adherence , ultimately , clinical outcome . Adherence data primarily derive Easypod™ device combine physician data entry outcome measure . Data collect retrospectively prospectively . This allow establishment adherence profile explore hypothesis patient adherence support program improve adherence subsequent clinical outcome . Collected data also analyze multinational pooled analysis comparable national study . Primary Objective : - To assess level adherence subject prescribe SAIZEN® via easypod™ Secondary Objectives : - To describe impact adherence clinical outcome subject prescribed SAIZEN via easypod™ - To identify adherence subject profiling</detailed_description>
	<mesh_term>Growth Disorders</mesh_term>
	<criteria>Prescribed SAIZEN® via easypod™ autoinjector ( SAIZEN® Health Canadian approve indication : Growth Hormone Insufficiency Deficiency , Turner 's Syndrome , Chronic Renal Failure , Small Gestational Age Under 18 year age , 18 without fusion growth plat Parent 's legal guardian 's write informed consent , give enter data registry , understand subject parent/legal guardian may withdraw consent time without prejudice future medical care . If child old enough read write , separate assent form give define Health Canada regulation . Adult consent define 18+ province Quebec , 16+ remainder Canada . Subjects take growth hormone growth plate fuse ( i.e . take growth hormone metabolic effect ) Contraindications SAIZEN® define SAIZEN® Canadian Product Monograph . Use investigational drug participation another interventional clinical study</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Growth disorder</keyword>
	<keyword>Saizen</keyword>
	<keyword>Easypod</keyword>
	<keyword>Growth hormone</keyword>
	<keyword>Pediatric subject</keyword>
</DOC>